BCAB
BioAtlaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
BCAB vs peer average
95/100
BCAB vs. peer average (A vs. D)
Grade spread
B 1 · D 2 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
APVO is the first available peer comparator.
Loose same-sector micro-cap comparator; useful mainly for liquidity, dilution, and event-risk framing rather than program overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BCAB
BioAtla
APVO
Aptevo Therapeutics
Grade
A
F
Momentum
88
18
Value
59
58
Sentiment
55
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs APVO
BCAB / APVO
Grade Position
Above peers
BCAB vs. peer average (A vs. D)
95/100
Momentum
88
BCABValue
59
BCABSentiment
55
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BCAB
APVO is the first peer returned for this comparison set.